We estimate that the CEO of Dolby Laboratories, Inc. ($DLB), Kevin Yeaman, received a compensation of $10,193,397 in 2025. This is an increase of 5.05% from an estimated $9,678,964 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on December 16, 2025. Note that parsing errors may occur.
You can track $DLB on Quiver Quantitative's $DLB stock dashboard.
$DLB Stock Insider Trading Activity
$DLB Stock insiders have traded $DLB stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $DLB stock by insiders over the last 6 months:
- KEVIN J YEAMAN (President and CEO) has made 0 purchases and 11 sales selling 213,432 shares for an estimated $15,102,702.
- JOHN D COULING (SVP, Entertainment) has made 0 purchases and 2 sales selling 13,437 shares for an estimated $907,582.
- SHRIRAM REVANKAR (SVP, Advanced Technology Group) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $721,090.
- MARK ANDREW SHERMAN (EVP, Gen. Counsel & Secretary) sold 4,500 shares for an estimated $304,035
- TONY A PROPHET sold 3,300 shares for an estimated $223,904
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DLB Stock Congressional Stock Trading
Members of Congress have traded $DLB stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $DLB stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 09/11, 06/24 and 2 sales worth up to $30,000 on 09/25, 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$DLB Stock Hedge Fund Activity
We have seen 209 institutional investors add shares of $DLB Stock stock to their portfolio, and 241 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC added 610,205 shares (+184.9%) to their portfolio in Q3 2025, for an estimated $44,160,535
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 524,014 shares (-64.9%) from their portfolio in Q3 2025, for an estimated $37,922,893
- FRONTIER CAPITAL MANAGEMENT CO LLC removed 510,801 shares (-41.3%) from their portfolio in Q3 2025, for an estimated $36,966,668
- AQR CAPITAL MANAGEMENT LLC removed 444,614 shares (-25.6%) from their portfolio in Q3 2025, for an estimated $32,176,715
- FIRST TRUST ADVISORS LP added 281,214 shares (+22.7%) to their portfolio in Q3 2025, for an estimated $20,351,457
- MORGAN STANLEY removed 238,632 shares (-3.4%) from their portfolio in Q3 2025, for an estimated $17,269,797
- PACER ADVISORS, INC. added 219,901 shares (+98.2%) to their portfolio in Q3 2025, for an estimated $15,914,235
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DLB Stock Analyst Ratings
Wall Street analysts have issued reports on $DLB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Rosenblatt issued a "Buy" rating on 11/19/2025
- Barrington Research issued a "Outperform" rating on 11/19/2025
- Tigress Financial issued a "Buy" rating on 08/15/2025
To track analyst ratings and price targets for $DLB Stock, check out Quiver Quantitative's $DLB forecast page.
$DLB Stock Price Targets
Multiple analysts have issued price targets for $DLB recently. We have seen 4 analysts offer price targets for $DLB in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Steven Frankel from Rosenblatt set a target price of $85.0 on 11/19/2025
- Patrick Sholl from Barrington Research set a target price of $95.0 on 11/19/2025
- Vikram Kesavabhotla from Baird set a target price of $74.0 on 09/05/2025
- Ivan Feinseth from Tigress Financial set a target price of $114.0 on 08/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
